Sulfuric Acid

Sulfuric Acid

SCHEMBL2813624

O=S(=O)([O-])[O-].[BiH3].[H+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL2015462 0.94 MEN1 (0.46)
Sulfuric Acid SCHEMBL22639011 0.94 MEN1 (0.46)
Sulfuric Acid SCHEMBL6656 0.94
Sulfuric Acid SCHEMBL14774742 0.88
Sulfuric Acid SCHEMBL4300990 0.88
Sulfuric Acid SCHEMBL10423680 0.88
Sulfuric Acid SCHEMBL14359910 0.88
Sulfuric Acid SCHEMBL4306352 0.88
Sulfuric Acid SCHEMBL78230 0.88
Sulfuric Acid SCHEMBL4306356 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4678725-A1 CO-GRANULES COMPRISING BLEACHING CATALYST, BLEACHING ACTIVATOR, BINDER AND ZINC OR BISMUTH SALT, AND BLEACHING AND CLEANING AGENT COMPRISING SAME Catexel GmbH (DE) 2026-01-14 EP claimed
EP-1683515-A2 Bismuth-containing compounds in topical dosage forms Josman Laboratories, Inc. (US) 2006-07-26 EP claimed
EP-0879035-B1 BISMUTH-CONTAINING COMPOSITIONS IN TOPICAL DOSAGE FORMS JOSMAN LAB INC (US) 2006-06-14 EP claimed
US-20060088481-A1 Topical oral dosage forms containing bismuth compounds ATHANIKAR NARAYAN K 2006-04-27 US claimed
US-6902738-B2 Topical oral dosage forms containing bismuth compounds JOSMAN LABORATORIES, INC. (US) 2005-06-07 US claimed
US-20030118517-A1 Topical oral dosage forms containing bismuth compounds ATHANIKAR NARAYAN K (US) 2003-06-26 US claimed
US-6426085-B1 BACTERICIDES JOSMAN LABORATORIES INC. 2002-07-30 US claimed
US-6379651-B1 ADMINISTERING AND INGESTING PERORAL TABLETS OF AN ANTIBIOTIC/ANTIBACTERIAL COMPOUND WITH A BISMUTH COMPOUND, AND CHEWING WITHIN ORAL CAVITY JOSMAN LABORATORIES 2002-04-30 US claimed
US-6372784-B1 STIMULANTING CELL PRODUCTION OR RELEASE OF GROWTH FACTORS JOSMAN LABORATORIES, INC. 2002-04-16 US claimed
EP-0879035-A4 BISMUTH-CONTAINING COMPOUNDS IN TOPICAL DOSAGE FORMS JOSMAN LAB INC (US) 2001-10-31 EP claimed
EP-0879035-A1 BISMUTH-CONTAINING COMPOUNDS IN TOPICAL DOSAGE FORMS Josman Laboratories, Inc. (US) 1998-11-25 EP claimed
WO-1997007757-A1 BISMUTH-CONTAINING COMPOUNDS IN TOPICAL DOSAGE FORMS JOSMAN LABORATORIES, INC. (US) 1997-03-06 WO claimed
US-20100248151-A1 METHOD OF MAKING A PRINTING PLATE FUJIFILM CORPORATION (JP) 2010-09-30 US disclosed
EP-1683515-A2 Bismuth-containing compounds in topical dosage forms Josman Laboratories, Inc. (US) 2006-07-26 EP disclosed
EP-0879035-B1 BISMUTH-CONTAINING COMPOSITIONS IN TOPICAL DOSAGE FORMS JOSMAN LAB INC (US) 2006-06-14 EP disclosed
US-20060088481-A1 Topical oral dosage forms containing bismuth compounds ATHANIKAR NARAYAN K 2006-04-27 US disclosed
WO-1997007757-A1 BISMUTH-CONTAINING COMPOUNDS IN TOPICAL DOSAGE FORMS JOSMAN LABORATORIES, INC. (US) 1997-03-06 WO disclosed
WO-1996024341-A9 CONCOMITANT TREATMENT WITH BISMUTH AND ANTIBACTERIALS 1996-10-03 WO disclosed
WO-1996024341-A1 CONCOMITANT TREATMENT WITH BISMUTH AND ANTIBACTERIALS ATHANIKAR NARAYAN KRISHNARAO (US) 1996-08-15 WO disclosed
WO-1996024342-A1 CONCOMITANT TREATMENT WITH ORAL BISMUTH COMPOUNDS ATHANIKAR NARAYAN KRISHNARAO (US) 1996-08-15 WO disclosed